Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.
Multiple sclerosis and alcohol use disorders: In-hospital mortality, extended hospital stays, and overexpenditures.
Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed.
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines.
Oxidative stress-related biomarkers in multiple sclerosis: a review.
Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders.
A study of dietary modification: Perceptions and attitudes of patients with multiple sclerosis.
Septin/anillin filaments scaffold central nervous system myelin to accelerate nerve conduction.
The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Chronic inflammatory demyelinating polyneuropathy associated with manic symptoms.
Context-Specific Function of S6K2 in Th Cell Differentiation.
Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases.
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
Electroconvulsive Therapy in Multiple Sclerosis.
Mental Illness And Brain Disease.
Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.
Traumatic brain injury: a risk factor for neurodegenerative diseases.
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.
Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.

Pages